Obstetrics & Gynecology Doctors in Pasadena, MD Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Dr. Alicia Wasserman Sussman, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8028 Ritchie Hwy Ste 134, Kaiser Permanente Severna Park Medical Center, Pasadena, MD 21122 Phone: 410-553-2400

Dr. Valerie Anne Jones, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8028 Ritchie Hwy, Pasadena, MD 21122 Phone: 410-553-4200

Dana M Lee, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4231 Postal Ct, Ste 102, Pasadena, MD 21122 Phone: 410-553-8260    Fax: 410-787-4846

Hovik Taymoorian, D.O., P.A. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8028 Ritchie Hwy, Suite 126, Pasadena, MD 21122 Phone: 410-768-6702    Fax: 410-768-6704

Dr. Myrna Malan Ortega, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8028 Ritchie Hwy Ste 309, Pasadena, MD 21122 Phone: 410-787-7000

News Archive

Mental health issues rapidly growing among older African American adults

A new, revealing literature review suggests that older African American adults are more likely to be diagnosed with depression, anxiety, and dementia.

Researchers discover a new promising target to improve HIV vaccines

In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus's outer envelope where a lineage of antibodies are able to dock and neutralize the virus.

Patients with chronic hepatitis C can benefit by drinking coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Isotechnika Pharma Inc. has released its financial results for the fourth quarter and year ended December 31, 2009 and provided a review of the Company's operational and scientific highlights for 2009

Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). AHUS is an ultra-rare, inherited, and life-threatening complement-inhibitor deficiency disease that often progresses to end-stage kidney disease or failure. The U.S. Food and Drug Administration granted orphan drug designation to Soliris for the same indication in May 2009. Soliris is not approved for the treatment of patients with aHUS.

Read more Medical News

› Verified 8 days ago